髋膝关节置换外科医生能否帮助应对骨质疏松症流行?
基于PearlDiver数据库2010年1月至2021年10月710,097例全髋关节置换(THA)和1,353,218例全膝关节置换(TKA)患者,分析骨质疏松筛查比例及5年脆性骨折/假体周围骨折累积发生率。53%的THA和55%的TKA患者被判定为骨质疏松高风险,其中仅12%和13%接受了术前双能X线吸收测定(DEXA)检查。高风险患者5年内脆性骨折和假体周围骨折累积发生率均高于低风险患者。
要点
- 53%的THA和55%的TKA患者为骨质疏松高风险,但仅12%和13%接受了术前DEXA筛查。
- 高风险患者5年脆性骨折风险:THA HR 2.1(95%CI 1.9-2.2),TKA HR 1.8(95%CI 1.7-1.9)。
- 高风险患者5年假体周围骨折风险:THA HR 1.7(95%CI 1.5-1.8),TKA HR 1.6(95%CI 1.4-1.7)。
核心结论
- 作者将高风险患者较高比例的脆性和假体周围骨折归因于骨质疏松的隐匿诊断,髋膝关节置换外科医生可通过启动筛查并将患者转诊至骨骼健康专家治疗来帮助减少这些骨质疏松相关并发症的发生率和负担。
研究设计与样本
- 回顾性数据库研究,使用PearlDiver数据库Mariner数据集,纳入2010年1月至2021年10月期间至少50岁、随访至少2年、排除恶性肿瘤诊断和因骨折指征行全关节置换的患者,最终分析54%(380,266例)的THA和59%(795,201例)的TKA患者,根据国家指南定义骨质疏松高风险。
主要发现
- 在THA患者中53%(201,450例)为骨质疏松高风险,TKA中55%(439,982例)为高风险。
- 高风险THA患者中12%(24,898/201,450)接受了术前DEXA扫描,高风险TKA患者中13%(57,022/439,982)接受了术前DEXA扫描。
- 5年内高风险患者较TKA低风险患者脆性骨折累积发生率更高:THA HR 2.1(95%CI 1.9-2.2),TKA HR 1.8(95%CI 1.7-1.9)。
- 5年内高风险患者较低风险患者假体周围骨折累积发生率更高:THA HR 1.7(95%CI 1.5-1.8),TKA HR 1.6(95%CI 1.4-1.7)。
- 以上所有比较p < 0.001。
关键数值与推荐
- 骨质疏松高风险根据数据库提供的人口统计学和合并症信息并按国家指南定义进行筛选。
- 观察高风险患者在3年内通过DEXA扫描进行骨质疏松筛查的比例。
临床怎么用
- 作者认为,髋膝关节置换外科医生可以通过启动筛查并将患者转诊至骨骼健康专家治疗,帮助减少骨质疏松相关并发症的发生率和负担。
- 作者建议未来研究可调查高风险患者中骨质疏松的比例、开发和评估适用于髋膝关节置换外科医生的实用骨骼健康筛查和治疗算法,并观察实施这些算法的成本效益。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoporosis is a known, modifiable risk factor for lower extremity periprosthetic fractures. Unfortunately, a high percentage of patients at risk of osteoporosis who undergo THA or TKA do not receive routine screening and treatment for osteoporosis, but there is insufficient information determining the proportion of patients undergoing THA and TKA who should be screened and their implant-related complications. QUESTIONS/PURPOSES: (1) What proportion of patients in a large database who underwent THA or TKA met the criteria for osteoporosis screening? (2) What proportion of these patients received a dual-energy x-ray absorptiometry (DEXA) study before arthroplasty? (3) What was the 5-year cumulative incidence of fragility fracture or periprosthetic fracture after arthroplasty of those at high risk compared with those at low risk of osteoporosis? METHODS: Between January 2010 and October 2021, 710,097 and 1,353,218 patients who underwent THA and TKA, respectively, were captured in the Mariner dataset of the PearlDiver database. We used this dataset because it longitudinally tracks patients across a variety of insurance providers throughout the United States to provide generalizable data. Patients at least 50 years old with at least 2 years of follow-up were included, and patients with a diagnosis of malignancy and fracture-indicated total joint arthroplasty were excluded. Based on this initial criterion, 60% (425,005) of THAs and 66% (897,664) of TKAs were eligible. A further 11% (44,739) of THAs and 11% (102,463) of TKAs were excluded because of a prior diagnosis of or treatment for osteoporosis, leaving 54% (380,266) of THAs and 59% (795,201) of TKAs for analysis. Patients at high risk of osteoporosis were filtered using demographic and comorbidity information provided by the database and defined by national guidelines. The proportion of patients at high risk of osteoporosis who underwent osteoporosis screening via DEXA scan within 3 years was observed, and the 5-year cumulative incidence of periprosthetic fractures and fragility fracture was compared between the high-risk and low-risk cohorts. RESULTS: In total, 53% (201,450) and 55% (439,982) of patients who underwent THA and TKA, respectively, were considered at high risk of osteoporosis. Of these patients, 12% (24,898 of 201,450) and 13% (57,022 of 439,982) of patients who underwent THA and TKA, respectively, received a preoperative DEXA scan. Within 5 years, patients at high risk of osteoporosis undergoing THA and TKA had a higher cumulative incidence of fragility fractures (THA: HR 2.1 [95% CI 1.9 to 2.2]; TKA: HR 1.8 [95% CI 1.7 to 1.9]) and periprosthetic fractures (THA: HR 1.7 [95% CI 1.5 to 1.8]; TKA: HR 1.6 [95% CI 1.4 to 1.7]) than those at low risk (p < 0.001 for all). CONCLUSION: We attribute the higher rates of fragility and periprosthetic fractures in those at high risk compared with those at low risk to an occult diagnosis of osteoporosis. Hip and knee arthroplasty surgeons can help reduce the incidence and burden of these osteoporosis-related complications by initiating screening and subsequently referring patients to bone health specialists for treatment. Future studies might investigate the proportion of osteoporosis in patients at high risk of having the condition, develop and evaluate practical bone health screening and treatment algorithms for hip and knee arthroplasty surgeons, and observe the cost-effectiveness of implementing these algorithms. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Agarwal AR, Malyavko A, Gu A, et al. Can Hip and Knee Arthroplasty Surgeons Help Address the Osteoporosis Epidemic? Clin Orthop Relat Res. 2023. PMID: 37395623. doi:10.1097/CORR.0000000000002743
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。